Prognostic value of serum neutrophil gelatinase-associated lipocalin in metastatic and nonmetastatic colorectal cancer

World Journal of Surgery

Volumn 37, Issue 5, 2013, Pages 1103-1109

  Martí, Josep ^a   Fuster, Josep ^a   Solà, Anna M ^b   Hotter, Georgina ^b   Molina, Rafael ^a   Pelegrina, Amalia ^a   Ferrer, Joana ^a   Deulofeu, Ramon ^a   Fondevila, Constantino ^a   García Valdecasas, Juan Carlos ^a  

^a UNIVERSITY OF BARCELONA   (Spain)

^b INST D INVESTIGACIONS B   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ACUTE PHASE PROTEIN; LCN2 PROTEIN, HUMAN; LIPOCALIN; ONCOPROTEIN; TUMOR MARKER;

ADULT; AGED; ARTICLE; BLOOD; CASE CONTROL STUDY; COLORECTAL TUMOR; EVALUATION; FEMALE; FOLLOW UP; HUMAN; MALE; METASTASIS; MIDDLE AGED; MORTALITY; PATHOLOGY; PREOPERATIVE PERIOD; RETROSPECTIVE STUDY; SURVIVAL; TREATMENT OUTCOME; TUMOR INVASION; TUMOR RECURRENCE; TUMOR VOLUME; VERY ELDERLY;

ACUTE-PHASE PROTEINS; ADULT; AGED; AGED, 80 AND OVER; CASE-CONTROL STUDIES; COLORECTAL NEOPLASMS; FEMALE; FOLLOW-UP STUDIES; HUMANS; LIPOCALINS; MALE; MIDDLE AGED; NEOPLASM INVASIVENESS; NEOPLASM METASTASIS; NEOPLASM RECURRENCE, LOCAL; PREOPERATIVE PERIOD; PROTO-ONCOGENE PROTEINS; RETROSPECTIVE STUDIES; SURVIVAL ANALYSIS; TREATMENT OUTCOME; TUMOR BURDEN; TUMOR MARKERS, BIOLOGICAL;

EID: 84885630831     PISSN: 03642313     EISSN: 14322323     Source Type: Journal    
DOI: 10.1007/s00268-013-1930-z     Document Type: Article

References (21)

1. Jemal A, Bray F, Center MM et al (2011) Global cancer statistics. CA Cancer J Clin 61:69-90
2. Khatri VP, Petrelli NJ, Belghiti J (2005) Extending the frontiers of surgical therapy for hepatic colorectal metastases: is there a limit? J Clin Oncol 23:8490-8499
3. Kargozaran H, Kahlenberg M, Khatri VP (2008) The implications of colorectal cancer molecular biology in clinical practice. Surg Oncol Clin N Am 17:341-355
4. Mutch MG (2007) Molecular profiling and risk stratification of adenocarcinoma of the colon. J Surg Oncol 96:693-703
5. Tejpar S (2007) The multidisciplinary management of gastrointestinal cancer: the use of molecular markers in the diagnosis and treatment of colorectal cancer. Best Pract Res Clin Gastroenterol 21:1071-1087
6. Tong Z, Wu X, Ovcharenko D et al (2005) Neutrophil gelatinaseassociated lipocalin as a survival factor. Biochem J 391(Pt 2): 441-448
7. Nielsen BS, Borregaard N, Bundgaard JR et al (1996) Induction of NGAL synthesis in epithelial cells of human colorectal neoplasia and inflammatory bowel diseases. Gut 38:414-420
8. Lee HJ, Lee EK, Lee KJ et al (2006) Ectopic expression of neutrophil gelatinase-associated lipocalin suppresses the invasion and liver metastasis of colon cancer cells. Int J Cancer 118: 2490-2497
9. Bolignano D, Donato V, Lacquaniti A et al (2010) Neutrophil gelatinase-associated lipocalin (NGAL) in human neoplasias: a new protein enters the scene. Cancer Lett 288:10-16
10. Mori K, Nakao K (2007) Neutrophil gelatinase-associated lipocalin as the real-time indicator of active kidney damage. Kidney Int 71:967-970
11. Landroø L, Damås JK, Flo TH et al (2008) Decreased serum lipocalin-2 levels in human immunodeficiency virus-infected patients: increase during highly active anti-retroviral therapy. Clin Exp Immunol 152:57-63
12. Martí J, Fuster J, Hotter G et al (2010) Serum neutrophil gelatinase- associated lipocalin in patients with colorectal liver metastases: preliminary results of an exploratory prospective study. Int J Biol Markers 25:21-26
13. Martí J, Modolo MM, Fuster J et al (2009) Prognostic factors and time-related changes influence results of colorectal liver metastases surgical treatment: a single-center analysis. World J Gastroenterol 15:2587-2594
14. Lacy AM, Delgado S, Castells A et al (2008) The long-term results of a randomized clinical trial of laparoscopy-assisted versus open surgery for colon cancer. Ann Surg 248:1-7
15. Fong Y, Fortner J, Sun RL et al (1999) Clinical score for predicting recurrence after hepatic resection for metastatic colorectal cancer: analysis of 1,001 consecutive cases. Ann Surg 230:309-318
16. Nordlinger B, Guiguet M, Vaillant JC et al (1996) Surgical resection of colorectal carcinoma metastases to the liver: a prognostic scoring system to improve case selection, based on 1,568 patients. Cancer 77:1254-1262
17. Hu H, Krasinskas A, Willis J (2011) Perspectives on current tumor-node-metastasis (TNM) staging of cancers of the colon and rectum. Semin Oncol 38:500-510
18. Stangl R, Altendorf-Hofmann A, Charnley RM et al (1994) Factors influencing the natural history of colorectal liver metastases. Lancet 343:1405-1410
19. Scheele J, Stangl R, Altendorf-Hofmann A (1990) Hepatic metastases from colorectal carcinoma: impact of surgical resection on the natural history. Br J Surg 77:1241-1246
20. Zhai ZW, Gu J (2012) Influence of tumor size on the prognosis in patients with colon cancer. Zhonghua Wei Chang Wai Ke Za Zhi 15:495-498
21. Cernaro V, Bolignano D, Donato V et al (2011) NGAL is a precocious marker of therapeutic response. Curr Pharm Des 17:844-849